BG103872A - Glycoconjugates of 20(s)-camptotecin - Google Patents

Glycoconjugates of 20(s)-camptotecin

Info

Publication number
BG103872A
BG103872A BG103872A BG10387299A BG103872A BG 103872 A BG103872 A BG 103872A BG 103872 A BG103872 A BG 103872A BG 10387299 A BG10387299 A BG 10387299A BG 103872 A BG103872 A BG 103872A
Authority
BG
Bulgaria
Prior art keywords
camptotecin
glycoconjugates
oncogenesis
thiourea
bound
Prior art date
Application number
BG103872A
Other languages
Bulgarian (bg)
English (en)
Inventor
Hans - Georg LERCHEN
Dem Bruch Karsten Von
Joerg Baumgarten
Michael Sperzel
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19801037A external-priority patent/DE19801037A1/de
Priority claimed from DE1998113137 external-priority patent/DE19813137A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG103872A publication Critical patent/BG103872A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Electrically Operated Instructional Devices (AREA)
BG103872A 1997-05-14 1999-11-10 Glycoconjugates of 20(s)-camptotecin BG103872A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19720043 1997-05-14
DE19737477 1997-08-28
DE19801037A DE19801037A1 (de) 1997-05-14 1998-01-14 Glycokonjugate von 20(S)-Camptothecin
DE1998113137 DE19813137A1 (de) 1998-03-25 1998-03-25 Glycokonjugate von 20(S)-Camptothecin
PCT/EP1998/002620 WO1998051703A1 (fr) 1997-05-14 1998-05-04 Glycoconjugues de 20(s)-camptothecine

Publications (1)

Publication Number Publication Date
BG103872A true BG103872A (en) 2000-07-31

Family

ID=27438596

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103872A BG103872A (en) 1997-05-14 1999-11-10 Glycoconjugates of 20(s)-camptotecin

Country Status (19)

Country Link
US (1) US6506734B1 (fr)
EP (1) EP0981542B1 (fr)
JP (1) JP2001526661A (fr)
CN (1) CN1255926A (fr)
AT (1) ATE272648T1 (fr)
AU (1) AU744425B2 (fr)
BG (1) BG103872A (fr)
BR (1) BR9809637A (fr)
CA (1) CA2291436A1 (fr)
HU (1) HUP0003174A3 (fr)
ID (1) ID23424A (fr)
IL (1) IL132534A0 (fr)
NO (1) NO995481D0 (fr)
NZ (1) NZ500990A (fr)
PL (1) PL336697A1 (fr)
SK (1) SK154899A3 (fr)
TR (1) TR199902775T2 (fr)
TW (1) TW495512B (fr)
WO (1) WO1998051703A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19909979A1 (de) * 1999-03-06 2000-09-07 Bayer Ag Verfahren zur Herstellung von Glycokonjugaten von 20(S)-Camptothecin
DE10005275A1 (de) * 2000-02-07 2001-08-09 Bayer Ag Neuartige Glycokonjugate
EP1219634A1 (fr) * 2000-12-27 2002-07-03 Bayer Aktiengesellschaft Glycoconjugués d'agents cytostatiques avec lien peptidique spécifiquement clivable
US6350756B1 (en) * 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6855720B2 (en) 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6403604B1 (en) 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
EP1238678A1 (fr) 2001-03-08 2002-09-11 Bayer Aktiengesellschaft Conjugués d'agents cytostatiques et de ligands d'intégrine activés par des enzymes
US6933302B2 (en) 2002-06-03 2005-08-23 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
US7766293B2 (en) * 2006-04-25 2010-08-03 Raffel Systems, Llc Lighted cup holder for seating arrangements
WO2014152718A1 (fr) 2013-03-15 2014-09-25 Arizona Board Of Regents, For And On Behalf Of Arizona State University Conjugués saccharidiques
EP2968381A4 (fr) * 2013-03-15 2016-11-30 Sidney Hecht Conjugués de médicament-séquence de liaison du sucre
CN103333172B (zh) * 2013-06-28 2015-09-30 兰州大学 喜树碱缩氨基硫脲类化合物及其制备方法和用途
CN105566338B (zh) * 2014-10-08 2017-11-21 兰州大学 一种喜树碱类化合物及其制备方法和用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4943579A (en) 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP2524803B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
NZ235329A (en) * 1989-09-15 1992-01-29 Res Triangle Inst 20(s or rs)-camptothecin derivatives and pharmaceutical compositions
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
DE4106101A1 (de) * 1991-02-27 1992-09-03 Bayer Ag Fucose-markierte cytostatika
JP3126799B2 (ja) 1992-03-31 2001-01-22 第一製薬株式会社 光学活性カンプトテシン誘導体及びその製法
DE4236237A1 (de) * 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
JP2610792B2 (ja) * 1993-02-26 1997-05-14 株式会社ディ・ディ・エス研究所 多糖誘導体および薬物担体
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
US5646159A (en) 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
US5646262A (en) * 1994-07-28 1997-07-08 Georgetown University Antisense oligonucleotides against hepatitis B viral replication
US5496830A (en) 1994-09-14 1996-03-05 Johns Hopkins University Inhibition of hemoflagellates by camptothecin compounds
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
DE19512484A1 (de) * 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
SG50747A1 (en) * 1995-08-02 1998-07-20 Tanabe Seiyaku Co Comptothecin derivatives
CA2192725C (fr) * 1995-12-28 2004-04-20 Kenji Tsujihara Derives de la camptothecine
PT934329E (pt) 1996-09-30 2002-05-31 Bayer Ag Glicoconjugados de derivados de camptotecina modificados (ligacao 20-o)
DE19640969A1 (de) * 1996-10-04 1998-04-16 Bayer Ag 20-0-verknüpfte Glycokonjugate von Camptothecin

Also Published As

Publication number Publication date
NZ500990A (en) 2000-09-29
CA2291436A1 (fr) 1998-11-19
TR199902775T2 (xx) 2000-07-21
HUP0003174A2 (hu) 2001-05-28
EP0981542A1 (fr) 2000-03-01
AU7761598A (en) 1998-12-08
PL336697A1 (en) 2000-07-03
JP2001526661A (ja) 2001-12-18
ID23424A (id) 2000-04-20
BR9809637A (pt) 2000-07-11
IL132534A0 (en) 2001-03-19
CN1255926A (zh) 2000-06-07
AU744425B2 (en) 2002-02-21
US6506734B1 (en) 2003-01-14
ATE272648T1 (de) 2004-08-15
WO1998051703A1 (fr) 1998-11-19
NO995481L (no) 1999-11-09
EP0981542B1 (fr) 2004-08-04
SK154899A3 (en) 2000-08-14
HUP0003174A3 (en) 2003-03-28
NO995481D0 (no) 1999-11-09
TW495512B (en) 2002-07-21

Similar Documents

Publication Publication Date Title
MX9709315A (es) Peptidos y compuestos que se unen a un receptor de trombopoyetina.
MY113497A (en) Peptides and compounds that bind to a receptor
NZ306653A (en) Isolated dna il-17 receptors
SE9704546D0 (sv) Novel compounds
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
BG104236A (en) Transgenous mammals producing oligosaccharides in their milk
MX339406B (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
CA2274149A1 (fr) Peptides et composes qui se lient a un recepteur
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
WO1996034107A3 (fr) Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
IL114294A0 (en) Sterol derivatives
MY104992A (en) Composition inducing a binding.
AU6832398A (en) Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
DE69434384D1 (de) Metalkomplexbildner
ZA965565B (en) Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits.
EP0671768A3 (fr) Améliorations en relation avec des électrodes pour LSI.
HK1017899A1 (en) Process for the preparation of 17-esters of 9alpha,21-dihalo-pregnane-11beta,17alphadiol-20-ones
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
AU3711597A (en) A novel galanin receptor
EP1064402A4 (fr) Modulation antisens de lfa-3
UA37217C2 (uk) Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, фармацевтична композиція та проміжні сполуки
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
ES2170377T3 (es) Composicion que contiene quitosana.